This opportunity is no longer accepting applications.
grant PAR-23-164

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

This grant opportunity is for research on creating and testing new radioligands used in brain imaging through PET or SPECT scans. It aims to gather data from these studies to support the use of promising PET ligands in clinical research. Researchers are encouraged to incorporate findings from past pre-clinical studies to evaluate the feasibility of these developments.

This Funding Opportunity Announcement (FOA) invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain and the incorporation of, pilot or…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Mental Health
Program: SBIR

Dates

Opportunity Released: April 7, 2023
Open for Submission: April 7, 2023
Submission Deadline: May 7, 2026
Application Window Closes: May 7, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.